‘Always willing to help and meet the interests of its clients’, Souto Correa Advogados established its life sciences practice in February 2022 and has continued to show its dedication to this field by recently expanding the team to 8 professionals, all focused on life sciences and healthcare. The group 'provides technical and strategic advice from a local regulatory perspective' to a diverse client base, with a particular focus on the pharmaceutical and food segments. Department head Anderson Ribeiro maintains a broad practice focused on regulations, government contracts, compliance, clinical trials, transactions and litigation. Key names below partner-level include: Matheus Montecasciano, who has considerable experience in administrative proceedings before ANVISA and other regulatory health authorities; Paulo Rosito, who often acts for pharmaceutical companies in non-contentious matters and litigation; and Lucas Calabria, who possesses in-depth knowledge of sanitary regulation, food and drug law.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Anderson Ribeiro is an excellent lawyer who understands the needs of the health sector.’
‘Extremely qualified team and always willing to help and meet the interests of the client. Fast and efficient, with great knowledge of the area and the pharmaceutical sector.’
‘Matheus Montecasciano is an excellent professional. He is always available to assist clients in the best way and within the requested deadlines. Anderson Ribeiro is highly knowledgeable of life sciences. Paulo Rosito is a great professional with excellent knowledge of how the industry works.’
'The life sciences department, led by Anderson Ribeiro, provides technical and strategic advice from a local regulatory perspective. It is well versed in the laws that apply to each industry and has excellent knowledge of how the local regulatory agency works.'
'Anderson Ribeiro is the key partner to watch out for. He knows each regulated industry very well and provides excellent advice on the best way to market regulated products in Brazil.'

Key clients

BioMarin Pharmaceutical
Henry Schein Brazil Dental
Young Living Essential Oils
IFF / Danisco
Vertex
Irani
Teva
Janssen Cilag / Johnson & Johnson
Laboratório Catarinense
Natulab
Chiesi Farmacêutica

Work highlights

Advising a rare disease company on preventing and nullifying an illegal public procurement conducted by the Health Secretariat of the State of Santa Catarina to purchase the drug by international vendors.
Representing a pharma company in a case to overturn the unfavourable price decision from CMED at the appeal level to enable the launching of a product with the potential to lead the weight loss market.
Advised a major food ingredient supplier on general advice regularly concerning local operations and the challenges of introducing novel ingredients and quality/regulatory compliance.